REGENERON PHARMACEUTICALS, INC. Annual Return On Equity in % from 2010 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Regeneron Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2010 to 2023.
  • Regeneron Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was 16.9 %, a 0.36% increase year-over-year.
  • Regeneron Pharmaceuticals, Inc. annual Return On Equity for 2023 was 16.1 %, a 21.5% decline from 2022.
  • Regeneron Pharmaceuticals, Inc. annual Return On Equity for 2022 was 20.5 %, a 60% decline from 2021.
  • Regeneron Pharmaceuticals, Inc. annual Return On Equity for 2021 was 51.2 %, a 54.2% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 16.1 -4.41 -21.5% Jan 1, 2023 Dec 31, 2023
2022 20.5 -30.7 -60% Jan 1, 2022 Dec 31, 2022
2021 51.2 +18 +54.2% Jan 1, 2021 Dec 31, 2021
2020 33.2 +12.4 +60% Jan 1, 2020 Dec 31, 2020
2019 20.8 -11.4 -35.5% Jan 1, 2019 Dec 31, 2019
2018 32.2 +11 +51.6% Jan 1, 2018 Dec 31, 2018
2017 21.2 -0.12 -0.56% Jan 1, 2017 Dec 31, 2017
2016 21.3 +2.16 +11.3% Jan 1, 2016 Dec 31, 2016
2015 19.2 +5.22 +37.4% Jan 1, 2015 Dec 31, 2015
2014 14 -11.3 -44.7% Jan 1, 2014 Dec 31, 2014
2013 25.3 -89 -77.9% Jan 1, 2013 Dec 31, 2013
2012 114 +161 Jan 1, 2012 Dec 31, 2012
2011 -46.4 -20.9 -81.5% Jan 1, 2011 Dec 31, 2011
2010 -25.6 Jan 1, 2010 Dec 31, 2010
* An asterisk sign (*) next to the value indicates that the value is likely invalid.